#hematology Archives

ASH 2024 | Dr. Qian Jiang: Groundbreaking Leukemia Research and the Future of the Field

By Peng Longmei 2024.12.31

Editor's Note: The 66th Annual Meeting of the American Society of Hematology (ASH) took place in San Diego from December 7 to 10, 2024. This global event brought together leading…

ASH 2024 | Dr. Wenming Chen: Precision and Immune-Targeted Therapies to Overcome R/R MM Challenges

By Mourabit Halima 2024.12.31

Editor's Note: The 66th Annual Meeting of the American Society of Hematology (ASH) took place in San Diego from December 7 to 10, 2024. This prestigious event brought together global…

Dr. Sizhou Feng’s Team Breakthroughs: Identifying Infection Risk Factors and Optimizing Differential Diagnosis Strategies for Hematological Patients

By Ren Jiamo 2024.12.26

Editorial Note: Neutropenia, immunosuppressive treatments, and various other factors make patients with hematological disorders particularly susceptible to infections from diverse pathogens. These infections often progress rapidly, with high mortality rates,…

the Role of the Pinch-Cxcl12-Mbl2 Pathway in Immune and Hematopoietic Homeostasis: Implications for Therapeutic Interventions

By Mourabit Halima 2024.03.15

Editor's note: The interplay between bone marrow stromal cells (BMSCs) and immune as well as hematopoietic functions is a complex yet crucial aspect of maintaining overall health. In this study,…

Intensified Conditioning Regimens for High-Risk ALL Patients Undergoing Allo-HSCT: A Retrospective Analysis

By Mourabit Halima 2024.03.15

Editor's note: The prognosis of high-risk acute lymphoblastic leukemia (ALL) patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT) remains variable, particularly concerning minimal residual disease (MRD) status. Professor Yu Hu…

Enhancing Early Infection Risk Prediction in Newly Diagnosed Multiple Myeloma: A Nomogram Prognostic Model Approach

By Mourabit Halima 2024.03.15

Editor's note: In patients with newly diagnosed multiple myeloma (NDMM), infections pose a significant threat to morbidity and mortality, particularly within the initial months post-diagnosis. Immunoparesis, characterized by reduced levels…

Mutation landscape of normal karyotype myelodysplastic syndromes and their prognostic impact

By Mourabit Halima 2024.03.08

In February 2024, a study led by Professor Hongyan Tong from the First Affiliated Hospital, Zhejiang University School of Medicine was published in the international academic journal ——American Journal of…

Time-Dependent Effects of Early-Onset Epstein-Barr Viremia on Adult Acute Leukemia Patients Following Allo-HSCT with ATG-Containing MAC Regimen

By Mourabit Halima 2024.03.08

In July 2021, a study led by Professor Zhengzheng Fu from the First Affiliated Hospital of Soochow University was published in the international academic journal ——Annals of Hematology. The title…

Ectopic expression of transcription factor ONECUT3 drives complex karyotype in Myelodysplastic Syndromes

By Mourabit Halima 2024.03.07